Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shore Capital downgrades Victorian Plumbing to 'hold'

(Sharecast News) - Shore Capital has cut its rating for Victorian Plumbing from 'buy' to 'hold' following some mixed first-half results from the bathroom specialist last month, raising concerns about profitability. The broker highlighted a "strong performance" from the company in the second quarter, delivering revenue growth of 9% following a slower start to the year.

However, higher depreciation and interest led management to cut its full-year profit before tax guidance to £23-24m, compared with estimates of a figure closer to £27m.

Victorian Plumbing also announced the relaunching of the MFI brand as an online pureplay home and furniture specialist, which Shore Capital said offers "significant revenue potential" but at a short-term cost of £6m of profit over the next two years.

Despite the company's "strong track record of growth", Shore Capital had some reservations about the move: "While we welcome the entrepreneurial spirit, we view the expansion into Home as one that may pose some challenges for VIC, given the strong existing competition (e.g. Dunelm, DFS, JLP, Next, Ikea), the expectations of lower margins versus the core business and the fact that online penetration appears stagnant post-COVID."

The broker has lowered its fair value estimate for Victorian Plumbling's shares to just 80p, from 130p previously.

The stock was more or less flat at 77p by 1559 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.